Synta Pharmaceuticals Corp.
- Country
- 🇺🇸United States
- Ownership
- Private, Subsidiary
- Established
- 2000-01-01
- Employees
- 51
- Market Cap
- -
- Website
- http://www.syntapharma.com
STA-5326 in Crohn's Disease Patients
- Conditions
- First Posted Date
- 2004-07-21
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- Synta Pharmaceuticals Corp.
- Target Recruit Count
- 48
- Registration Number
- NCT00088062
- Locations
- 🇺🇸
Heart of America Research Institute, Topeka, Kansas, United States
🇺🇸Boston Medical Center, Boston, Massachusetts, United States
🇺🇸Venture Research Institute, LLC, North Miami Beach, Florida, United States
STA-4783 and Paclitaxel for Treatment of Solid Tumors
- Conditions
- First Posted Date
- 2004-07-21
- Last Posted Date
- 2014-03-06
- Lead Sponsor
- Synta Pharmaceuticals Corp.
- Target Recruit Count
- 50
- Registration Number
- NCT00088114
- Locations
- 🇺🇸
Beth Israel-Deaconess Medical Center, Boston, Massachusetts, United States
🇺🇸Dana Farber Cancer Institute, Boston, Massachusetts, United States
STA-5312 Administered on Alternate Weekdays Every Two Weeks to Patients With Hematologic Malignancies and Patients With Solid Tumors
- Conditions
- First Posted Date
- 2004-07-21
- Last Posted Date
- 2008-12-04
- Lead Sponsor
- Synta Pharmaceuticals Corp.
- Target Recruit Count
- 42
- Registration Number
- NCT00088101
- Locations
- 🇺🇸
University of Chicago, Chicago, Illinois, United States
🇺🇸Tufts New England Medical Center, Boston, Massachusetts, United States
🇺🇸Newark Beth Israel Medical Center, Newark, New Jersey, United States
STA-4783 in Combination With Paclitaxel and Carboplatin for the Treatment of Chemotherapy Naive Patients With Stage IIIB/IV Non Small Cell Lung Cancer (NSCLC)
- Conditions
- First Posted Date
- 2004-07-21
- Last Posted Date
- 2008-12-04
- Lead Sponsor
- Synta Pharmaceuticals Corp.
- Target Recruit Count
- 86
- Registration Number
- NCT00088088
- Locations
- 🇺🇸
Cancer Institute Medical Group, Santa Monica, California, United States
🇺🇸Oncology Hematology Consultants, Sarasota, Florida, United States
🇺🇸Overton Brooks, VAMC, Shreveport, Louisiana, United States
STA-4783/Paclitaxel or Paclitaxel Alone in Melanoma
- Conditions
- First Posted Date
- 2004-06-10
- Last Posted Date
- 2014-03-06
- Lead Sponsor
- Synta Pharmaceuticals Corp.
- Target Recruit Count
- 103
- Registration Number
- NCT00084214
- Locations
- 🇺🇸
Genesis Cancer Center, Hot Springs, Arkansas, United States
🇺🇸Piedmont Oncology Specialists, Charlotte, North Carolina, United States
🇺🇸James Graham Brown Cancer Center - University Of Louisville, Louisville, Kentucky, United States